Balkan, II; Dogan, M; Durdu, B; Batirel, A; Hakyemez, IN; Cetin, B; Karabay, O; Gonen, I; Ozkan, AS; Uzun, S; Demirkol, ME; Akbas, S; Kacmaz, AB; Aras, S; Mert, A; Tabak, F
(2014)
Background: Colistin (COL) has become the backbone of the treatment of infections due to extensively drug-resistant (XDR) Gram-negative bacteria. The most common restriction to its use is acute kidney injury (AKI). Methods: ...